Volume 1 Supplement 1

Fourth International Synovitis Workshop

Open Access

Chemokines in Rheumatoid Arthritis

  • Alisa Koch1
Arthritis Research & Therapy19991(Suppl 1):S23

https://doi.org/10.1186/ar37

Published: 15 November 1999

Full text

We examined the role of chemokines, which recruit a variety of cells, including leukocytes and endothelial cells, in rheumatoid arthritis (RA). We determined the role of the angiogenic chemokines IL-8 and epithelial neutrophil activating peptide-78 (ENA-78) in RA using a whole synovial tissue (ST) homogenate model. RA ST homogenates produced greater levels of these chemokines than did normal ST homogenates. Angiogenic chemokines often immunolocalized in proximity to ST blood vessels. RA ST homogenates contained more angiogenic activity in vitro and angiogenic activity in vivo than did normal ST extracts. Hence, IL-8 and ENA-78 are major contributors to the RA ST angiogenic activity in vitro and in vivo. To determine the role of chemokines in the development of arthritis, we examined inflammation in rats. Anti-ENA-78 diminished peritoneal neutrophil recruitment in response to rhENA-78 or lipopolysaccaride. In adjuvant-induced arthritis (AIA), a model for RA, rats produced serum ENA-78 from day 7 post adjuvant induction, even prior to the onset of clinical AIA. Joint ENA-78 was elevated in AIA rats from the onset of clinical arthritis. Prophylactic therapy of rat AIA with anti-ENA-78 prior to clinical disease onset resulted in a reduction of arthritis and a decrease in joint IL-1β and tumor necrosis factor (TNF)-α. These results suggest a role for ENA-78 in the early stages of AIA development. Efforts aimed at eliminating these angiogenic chemokines may be of benefit in the therapy of RA.

Authors’ Affiliations

(1)
Northwestern University

References

  1. Koch AE, Kunkel SL, Burrows JC, et al: The synovial tissue macrophage as a source of the chemotactic cytokine interleukin-8. J Immunol. 1991, 147: 2187-2195.PubMedGoogle Scholar
  2. Koch AE, Kunkel SL, Harlow LA, et al: Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest. 1992, 90: 772-779.PubMedPubMed CentralView ArticleGoogle Scholar
  3. Koch AE, Polverini PJ, Kunkel SL, et al: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992, 258: 1798-1801.PubMedView ArticleGoogle Scholar
  4. Koch AE, Kunkel SL, Harlow LA, et al: Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest. 1994, 94: 1012-1018.PubMedPubMed CentralView ArticleGoogle Scholar
  5. Koch AE: Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 1998, 41: 951-962. 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D.PubMedView ArticleGoogle Scholar
  6. Halloran MM, Szekanecz Z, Strieter RM, et al: The role of epithelial neutrophil activating peptide-78 in rat adjuvant-induced arthritis, a model for human rheumatoid arthritis. J Immunol. 1999, 162: 7492-7500.PubMedGoogle Scholar
  7. Koch AE, Strieter RM: . The role of chemokines in disease. Austin: RG Landes Company (and Chapman and Hall). 1996Google Scholar

Copyright

© Current Science Ltd 2000

Advertisement